“A Trial of Unrelated Donor Marrow Transplantation for Children with Severe Sickle Cell Disease”, Blood, vol. 128, no. 21, pp. 2561-2567, 2016.,
“Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies”, Biol Blood Marrow Transplant, vol. 20, pp. 1485-1492, 2014.,
“One-Unit Versus Two-Unit Cord-Blood Transplantation for Hematologic Cancers”, N Engl J Med, vol. 371, pp. 1685-1694, 2014.,
“Fludarabine-Based Conditioning for Marrow Transplantation From Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose De-Escalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels”, Biol Blood Marrow Transplant, vol. 18, pp. 1007-1011, 2012.,
“Lack of Enhanced Survival after Double Umbilical Cord Blood (UCB) Transplant Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the BMT-CTN Randomized Trial”, in 54th Annual ASH Meeting, Atlanta, GA, 2012.,
“Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)”, Biol Blood Marrow Transplant, vol. 18, pp. 1265-1272, 2012.,
“Alternative Donor Transplantation: Results of Parallel Phase II Trials Using HLA-Mismatched Related Bone Marrow or Unrelated Umbilical Cord Blood Grafts”, Blood, vol. 118, no. 2, pp. 282-288, 2011.